Can Medidata beat analyst estimates?; IBM's next big thing in chip technology;

> DailyFinance asks whether clinical trials software provider Medidata Solutions ($MDSO) has what it takes to beat analysts' estimates in its earnings. News

> NGDATA has certified its Lily software on Cloudera's Distribution Including Apache Hadoop Version 4 (CDH4), providing a Big Data enterprise software that could be of interest to companies in pharma and other industries. Release

> PharmaTimes asks stakeholders what it takes to sell managers on digital initiatives. Item

> Genpact ($G), a global IT outsourcing provider, was named a leader in IDC's report on pharma social media analytics. Item

And Finally… IBM ($IBM) offers evidence of how carbon nanotubes can boost chip performance for years to come. Blog



Suggested Articles

There's no evidence personal patient information leaked during the 11-week breach, but the same can't be said about Sangamo's own secrets.

Through a new online tracker, AllTrials names sponsors who fail to report clinical trial results on time per the FDAAA Final Rule.

The new solution aims to streamline the incorporation of human genomic data into clinical trial designs.